Healthcare Innovation May 6, 2024
Benjamin Hippen, M.D., head of transplant medicine and emerging capabilities at Fresenius Medical Care, discusses his recently published proposal
The CMS Center for Medicare & Medicaid Innovation (CMMI) has developed several value-based care models that address chronic kidney disease and end-stage kidney disease. In a recent interview, nephrologist Benjamin Hippen, M.D., senior vice president, head of transplant medicine and emerging capabilities at Fresenius Medical Care, explained why it is important that future models include the entire spectrum of kidney disease, including transplantation.
Hippen co-authored a recent article in Kidney International Reports and will speak at the American Transplant Congress in June, outlining a value-based care approach that’s inclusive of kidney transplant and post-transplant care.
Healthcare Innovation: We’ve written about some...